Jane Street
GH icon

Jane Street’s Guardant Health GH Stock Holding History

Jane Street’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.3M Buy
355,200
+254,200
+252% +$27.6M ﹤0.01% 1372
2026
Q1 		$9.33M Sell
101,000
-237,900
-70% -$23.9M ﹤0.01% 2626
2025
Q4 		$34.6M Sell
338,900
-116,400
-26% -$10.4M 0.01% 1151
2025
Q3 		$28.4M Buy
455,300
+116,700
+34% +$6.35M ﹤0.01% 1342
2025
Q2 		$17.6M Buy
338,600
+26,500
+8% +$1.18M ﹤0.01% 1574
2025
Q1 		$13.3M Buy
312,100
+262,200
+525% +$11.3M ﹤0.01% 1666
2024
Q4 		$1.52M Sell
49,900
-188,700
-79% -$5.31M ﹤0.01% 4604
2024
Q3 		$5.47M Buy
238,600
+155,200
+186% +$4.39M ﹤0.01% 2717
2024
Q2 		$2.41M Buy
83,400
+62,800
+305% +$1.46M ﹤0.01% 4175
2024
Q1 		$425K Sell
20,600
-112,200
-84% -$2.41M ﹤0.01% 6966
2023
Q4 		$3.59M Sell
132,800
-45,400
-25% -$1.19M ﹤0.01% 3344
2023
Q3 		$5.28M Buy
178,200
+53,800
+43% +$1.89M ﹤0.01% 2537
2023
Q2 		$4.45M Sell
124,400
-45,400
-27% -$1.3M ﹤0.01% 2916
2023
Q1 		$3.98M Sell
169,800
-63,600
-27% -$1.82M ﹤0.01% 2759
2022
Q4 		$6.35M Buy
233,400
+85,300
+58% +$3.9M ﹤0.01% 2171
2022
Q3 		$7.97M Sell
148,100
-169,600
-53% -$8.71M ﹤0.01% 1959
2022
Q2 		$12.8M Buy
317,700
+179,700
+130% +$8.9M 0.01% 1483
2022
Q1 		$9.14M Buy
138,000
+18,200
+15% +$1.25M ﹤0.01% 2112
2021
Q4 		$12M Buy
119,800
+5,500
+5% +$569K ﹤0.01% 1678
2021
Q3 		$14.3M Buy
114,300
+19,200
+20% +$2.28M 0.01% 1402
2021
Q2 		$11.8M Buy
95,100
+57,100
+150% +$7.68M ﹤0.01% 1537
2021
Q1 		$5.8M Sell
38,000
-12,700
-25% -$1.92M ﹤0.01% 2195
2020
Q4 		$6.53M Sell
50,700
-13,300
-21% -$1.53M ﹤0.01% 1808
2020
Q3 		$7.15M Buy
64,000
+30,100
+89% +$2.75M ﹤0.01% 1500
2020
Q2 		$2.75M Sell
33,900
-19,600
-37% -$1.58M ﹤0.01% 2626
2020
Q1 		$3.72M Buy
53,500
+10,000
+23% +$767K ﹤0.01% 1416
2019
Q4 		$3.4M Buy
43,500
+20,700
+91% +$1.49M ﹤0.01% 1403
2019
Q3 		$1.46M Buy
+22,800
New +$2.01M ﹤0.01% 2150

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Jane Street's GH Position: Q2 2026 in Review

Jane Street increased its Guardant Health (GH) stake by 37,032% in Q2 2026, buying an estimated $193M and bringing the position to 1,783,444 shares worth $268M. The position accounts for 0.02% of the portfolio, ranked #467.

Jane Street first reported a position in GH in Q2 2019 and has held it in 28 quarters since. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Jane Street held 1,783,444 shares of Guardant Health worth $268M as of Q2 2026.
  • Jane Street bought 1,778,641 Guardant Health shares in Q2 2026, an estimated $193M.
  • Guardant Health made up 0.02% of Jane Street's portfolio in Q2 2026, its #467 holding.
  • Jane Street first reported a position in Guardant Health in Q2 2019 and has held it in 28 quarters since.
  • 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.